880
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Osteopontin but not parathyroid hormone-related protein predicts prognosis in human renal cell carcinoma

, , , , &
Pages 159-165 | Received 11 Jul 2011, Accepted 04 May 2012, Published online: 26 Jun 2012

Figures & data

Table I. Summary of the materials used in the study based on a total of 269 patients with renal cell carcinoma.

Figure 1. Kaplan-Meier plots of RCC-specific survival according to the median level of OPN in (A). plasma in 76 patients with cRCC diagnosed 2001–2006 (median 120 ng/mL), and (B). serum in 118 patients with cRCC diagnosed 1982–1997 (median 40 ng/mL).

Figure 1. Kaplan-Meier plots of RCC-specific survival according to the median level of OPN in (A). plasma in 76 patients with cRCC diagnosed 2001–2006 (median 120 ng/mL), and (B). serum in 118 patients with cRCC diagnosed 1982–1997 (median 40 ng/mL).

Table II. Multivariate analysis evaluating age, gender, TNM stage, nuclear grade and ostepontin (OPN) levels in relation to disease-specific survival of patients with clear cell RCC.

Figure 2. Parathyroid hormone-related protein expression in renal cell carcinoma. No (A) and strong (B) immunohistochemical expression of PTHrP (polyclonal guinea pig antibody T5045, Bachem, Switzerland), 20 × magnification.

Figure 2. Parathyroid hormone-related protein expression in renal cell carcinoma. No (A) and strong (B) immunohistochemical expression of PTHrP (polyclonal guinea pig antibody T5045, Bachem, Switzerland), 20 × magnification.

Table III. Correlations between immunohistochemical expression of PTHrP and serum PTHrP, CD 31 tumour expression, serum calcium and serum OPN in 189 patients with renal cell carcinoma.

Supplemental material

http://informahealthcare.com/doi/abs/10.3109/0284186X.2012.693623

Download PDF (138.1 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.